Home268600 • KOSDAQ
add
Cellivery Therapeutics Inc
Previous close
₩6,680.00
Year range
₩6,680.00 - ₩6,680.00
Market cap
244.25B KRW
P/E ratio
-
Dividend yield
-
Primary exchange
KOSDAQ
Market news
Financials
Income Statement
Revenue
Net income
(KRW) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | 1.50B | -68.77% |
Operating expense | 1.19B | -58.01% |
Net income | -1.40B | 88.63% |
Net profit margin | -93.19 | 63.58% |
Earnings per share | — | — |
EBITDA | -289.66M | 91.40% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(KRW) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 64.82M | -96.13% |
Total assets | 22.70B | -49.44% |
Total liabilities | 44.73B | -31.00% |
Total equity | -22.03B | — |
Shares outstanding | 37.14M | — |
Price to book | -12.36 | — |
Return on assets | -11.30% | — |
Return on capital | -17.89% | — |
Cash Flow
Net change in cash
(KRW) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -1.40B | 88.63% |
Cash from operations | -508.99M | 56.17% |
Cash from investing | 226.95M | -78.11% |
Cash from financing | -242.98M | 92.86% |
Net change in cash | -525.01M | 85.15% |
Free cash flow | -1.06B | -104.64% |
About
CEO
Founded
2014
Website
Employees
4